
  <style>
  .gh-table table { 
    border-collapse: collapse; 
    width: 100%;
    border: 1px solid #444;
    font-size: 12px;
  }
  .gh-table th, .gh-table td { 
    border: 1px solid #444; 
    padding: 4px 6px; 
    vertical-align: top;
    font-weight: 400 !important;   /* regular font */
  }
  .gh-table th { 
    .gh-table th { background: #f5f5f5; text-align: left; }
  }
  .gh-table th { font-weight: 700 !important; }
    @media print {
      .gh-table { font-size: 10px; }
    }
  </style>
  <div class='gh-table'><table><thead><tr><th>record_id</th><th>visit</th><th>Molecola (1)</th><th>Molecola (2)</th><th>description</th></tr></thead><tbody><tr><td>ZA16</td><td>1</td><td>Canrenone</td><td>Acetylsalicylic acid</td><td>Acetylsalicylic acid may decrease the excretion rate of Canrenone which could
result in a higher serum level.</td></tr><tr><td>ZA16</td><td>1</td><td>Canrenone</td><td>Amlodipine</td><td>The risk or severity of hyperkalemia can be increased when Amlodipine is
combined with Canrenone.</td></tr><tr><td>ZA16</td><td>1</td><td>Canrenone</td><td>Indapamide</td><td>Canrenone may increase the excretion rate of Indapamide which could result in a
lower serum level and potentially a reduction in efficacy.</td></tr><tr><td>ZA16</td><td>1</td><td>Esomeprazole</td><td>Amlodipine</td><td>The metabolism of Esomeprazole can be decreased when combined with Amlodipine.</td></tr><tr><td>ZA16</td><td>1</td><td>Indapamide</td><td>Acetylsalicylic acid</td><td>Acetylsalicylic acid may decrease the excretion rate of Indapamide which could
result in a higher serum level.</td></tr><tr><td>ZA16</td><td>1</td><td>Indapamide</td><td>Cholecalciferol</td><td>The risk or severity of hypokalemia can be increased when Cholecalciferol is
combined with Indapamide.</td></tr><tr><td>ZA16</td><td>1</td><td>Levothyroxine</td><td>Acetylsalicylic acid</td><td>The therapeutic efficacy of Levothyroxine can be increased when used in
combination with Acetylsalicylic acid.</td></tr><tr><td>ZA16</td><td>1</td><td>Levothyroxine</td><td>Esomeprazole</td><td>Esomeprazole can cause a decrease in the absorption of Levothyroxine resulting
in a reduced serum concentration and potentially a decrease in efficacy.</td></tr><tr><td>ZA16</td><td>1</td><td>Nebivolol</td><td>Acetylsalicylic acid</td><td>Acetylsalicylic acid may decrease the antihypertensive activities of Nebivolol.</td></tr><tr><td>ZA16</td><td>1</td><td>Nebivolol</td><td>Canrenone</td><td>The risk or severity of hyperkalemia can be increased when Nebivolol is combined
with Canrenone.</td></tr><tr><td>ZA16</td><td>1</td><td>Nebivolol</td><td>Cholecalciferol</td><td>The metabolism of Nebivolol can be decreased when combined with Cholecalciferol.</td></tr><tr><td>ZA16</td><td>1</td><td>Nebivolol</td><td>Esomeprazole</td><td>The metabolism of Nebivolol can be decreased when combined with Esomeprazole.</td></tr><tr><td>ZA16</td><td>1</td><td>Nebivolol</td><td>Indapamide</td><td>The therapeutic efficacy of Indapamide can be increased when used in combination
with Nebivolol.</td></tr><tr><td>ZA16</td><td>1</td><td>Nebivolol</td><td>Levothyroxine</td><td>The therapeutic efficacy of Levothyroxine can be decreased when used in
combination with Nebivolol.</td></tr><tr><td>ZA16</td><td>1</td><td>Perindopril</td><td>Acetylsalicylic acid</td><td>The therapeutic efficacy of Perindopril can be decreased when used in
combination with Acetylsalicylic acid.</td></tr><tr><td>ZA16</td><td>1</td><td>Perindopril</td><td>Canrenone</td><td>The risk or severity of hyperkalemia can be increased when Canrenone is combined
with Perindopril.</td></tr><tr><td>ZA16</td><td>1</td><td>Perindopril</td><td>Nebivolol</td><td>Perindopril may increase the hypotensive activities of Nebivolol.</td></tr><tr><td>ZA16</td><td>1</td><td>Rosuvastatin</td><td>Esomeprazole</td><td>The excretion of Rosuvastatin can be decreased when combined with Esomeprazole.</td></tr><tr><td>ZA16</td><td>1</td><td>Tenofovir alafenamide</td><td>Acetylsalicylic acid</td><td>The serum concentration of Tenofovir alafenamide can be increased when it is
combined with Acetylsalicylic acid.</td></tr><tr><td>ZA16</td><td>1</td><td>Tenofovir alafenamide</td><td>Amlodipine</td><td>The metabolism of Tenofovir alafenamide can be decreased when combined with
Amlodipine.</td></tr><tr><td>ZA16</td><td>1</td><td>Tenofovir alafenamide</td><td>Esomeprazole</td><td>The excretion of Tenofovir alafenamide can be decreased when combined with
Esomeprazole.</td></tr><tr><td>ZA16</td><td>1</td><td>Tenofovir alafenamide</td><td>Indapamide</td><td>The serum concentration of Tenofovir alafenamide can be increased when it is
combined with Indapamide.</td></tr><tr><td>ZA16</td><td>1</td><td>Tenofovir alafenamide</td><td>Levothyroxine</td><td>The serum concentration of Tenofovir alafenamide can be decreased when it is
combined with Levothyroxine.</td></tr><tr><td>ZA16</td><td>1</td><td>Tenofovir alafenamide</td><td>Perindopril</td><td>The serum concentration of Tenofovir alafenamide can be increased when it is
combined with Perindopril.</td></tr><tr><td>ZA16</td><td>1</td><td>Tenofovir alafenamide</td><td>Rosuvastatin</td><td>The excretion of Tenofovir alafenamide can be decreased when combined with
Rosuvastatin.</td></tr></tbody></table></div>
